

<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xmlns:xlink="https://www.w3.org/1999/xlink">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Avicenna J Med Biotech</journal-id>
      <journal-id journal-id-type="publisher-id">arij002</journal-id>
      <journal-title-group>
        <journal-title>Avicenna Journal of Medical Biotechnology</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">2008-2835</issn>
      <issn pub-type="epub">2008-4625</issn>
      <publisher>
        <publisher-name>Avicenna Research Institute</publisher-name>
      </publisher>
    </journal-meta>

    <article-meta>
      <article-id pub-id-type="publisher-id">ajmb331</article-id>
      <article-id pub-id-type="doi"></article-id>
      <article-id pub-id-type="pmid"></article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
             <subject></subject> 
        </subj-group>
        <subj-group>
            <subject></subject>
        </subj-group> 
      </article-categories>
      <title-group>
        <article-title>Association of G/C (rs638405) Polymorphism in &lt;i&gt;β-secretase&lt;/i&gt; Gene with Alzheimer’s Disease</article-title>
      </title-group>
        <contrib-group><contrib contrib-type="author"><name><surname>Chashmpoosh</surname><given-names>Mostafa</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Babaahmadi</surname><given-names>Hossein</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Mousavidehmordi</surname><given-names>Rouhollah</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Shalbafan</surname><given-names>Bita</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Mohammadi</surname><given-names>Asma</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Kheirollah</surname><given-names>Alireza</given-names></name></contrib></contrib-group>
      <pub-date pub-type="ppub">
        <day></day>
        <month></month>
        <year></year>
      </pub-date>
      <pub-date pub-type="epub">
        <day></day>
        <month></month>
        <year></year>
      </pub-date>
      <volume>10</volume>
      <issue>4</issue>
      <fpage>242</fpage>
      <lpage>247</lpage>
      <history>
        <date date-type="received">
          <day>22</day>
          <month>3</month>
          <year>2017</year>
        </date>
        <date date-type="accepted">
          <day>8</day>
          <month>7</month>
          <year>2017</year>
        </date>
      </history>
      <abstract>
      <p>
      &lt;p&gt;Background: Alzheimer&amp;#39;s Disease (AD) is a neurodegenerative disorder, which is the most common cause of dementia in the elderly. Accumulation of &amp;beta;-amyloid plaques outside neurons is the most important pathological hallmark of AD, which is produced by cleavage of amyloid precursor protein by the Alzheimer&amp;#39;s &amp;beta;-secretase (&lt;em&gt;BACE1&lt;/em&gt;). Since&amp;nbsp;&lt;em&gt;BACE1 &lt;/em&gt;is a key enzyme in the formation of &amp;beta;-amyloid peptides, the purpose of this study was to assess the association between polymorphisms of G/C (rs638405) &lt;em&gt;BACE1&lt;/em&gt; gene with sporadic AD in Khuzestan, Isfahan and Fars provinces in Iran.&lt;br /&gt;
Methods: Genotypes were determined by the PCR&amp;ndash;Restriction Fragment Length Polymorphism (PCR&amp;ndash;RFLP) technique in two groups including 89 sporadic AD patients and 73 healthy subjects.&lt;br /&gt;
Results: The findings of the &lt;em&gt;BACE1&lt;/em&gt; G/C (rs638405) polymorphism revealed that there was no significant difference between AD patients and controls in men group; however, there was a weak difference in the frequency of CC genotype between patients and controls in women group (&lt;em&gt;&amp;chi;&lt;/em&gt;&lt;sup&gt;2&lt;/sup&gt;=3.333, df=1, p=0.068).&lt;br /&gt;
Conclusion: The results of this study suggest that the G/C (rs638405) polymorphism of BACE1 gene might not be related with sporadic AD in Khuzestan, Isfahan and Fars provinces in Iran. However, our results do not support a genetic risk factor of this polymorphism for developing AD in male group of this study.&lt;/p&gt;

      </p>
      </abstract>
    </article-meta>
  </front>
    
</article>
